全文获取类型
收费全文 | 118666篇 |
免费 | 8872篇 |
国内免费 | 3400篇 |
专业分类
耳鼻咽喉 | 1156篇 |
儿科学 | 2478篇 |
妇产科学 | 1619篇 |
基础医学 | 13975篇 |
口腔科学 | 1801篇 |
临床医学 | 13716篇 |
内科学 | 19943篇 |
皮肤病学 | 880篇 |
神经病学 | 11303篇 |
特种医学 | 3210篇 |
外国民族医学 | 4篇 |
外科学 | 11087篇 |
综合类 | 15966篇 |
现状与发展 | 4篇 |
一般理论 | 2篇 |
预防医学 | 8467篇 |
眼科学 | 1199篇 |
药学 | 14280篇 |
71篇 | |
中国医学 | 4858篇 |
肿瘤学 | 4919篇 |
出版年
2024年 | 290篇 |
2023年 | 1854篇 |
2022年 | 3797篇 |
2021年 | 5386篇 |
2020年 | 4863篇 |
2019年 | 4067篇 |
2018年 | 4083篇 |
2017年 | 4429篇 |
2016年 | 4797篇 |
2015年 | 4752篇 |
2014年 | 8697篇 |
2013年 | 10103篇 |
2012年 | 7245篇 |
2011年 | 7860篇 |
2010年 | 6126篇 |
2009年 | 5972篇 |
2008年 | 5924篇 |
2007年 | 5406篇 |
2006年 | 4948篇 |
2005年 | 3966篇 |
2004年 | 3466篇 |
2003年 | 2952篇 |
2002年 | 2295篇 |
2001年 | 2059篇 |
2000年 | 1708篇 |
1999年 | 1486篇 |
1998年 | 1310篇 |
1997年 | 1182篇 |
1996年 | 1037篇 |
1995年 | 874篇 |
1994年 | 818篇 |
1993年 | 639篇 |
1992年 | 645篇 |
1991年 | 612篇 |
1990年 | 545篇 |
1989年 | 494篇 |
1988年 | 437篇 |
1987年 | 358篇 |
1986年 | 363篇 |
1985年 | 508篇 |
1984年 | 463篇 |
1983年 | 268篇 |
1982年 | 350篇 |
1981年 | 277篇 |
1980年 | 247篇 |
1979年 | 241篇 |
1978年 | 156篇 |
1977年 | 127篇 |
1976年 | 114篇 |
1975年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 327 毫秒
21.
Arvid Nikolai Kildahl Sissel Berge Helverschou Trine Lise Bakken Hanne Weie Oddli 《Journal of mental health research in intellectual disabilities》2020,13(3):201-230
ABSTRACT
Introduction
Individuals with autism spectrum disorder (ASD) and intellectual disability (ID) seem to be at increased risk for post-traumatic stress disorder (PTSD), but knowledge is sparse regarding its identification in this population. Previous research indicates that certain symptoms of PTSD may be more easily recognized, and that identifying reexperiencing and avoidance is particularly challenging. 相似文献22.
目的探讨脑卒中患者急性应激障碍发生现状及影响因素。方法采用斯坦福急性应激反应问卷对349例脑卒中住院患者进行调查。结果共163例(46.70%)患者发生急性应激障碍;Logistic回归分析结果显示,患者性格、是否存在偏瘫及是否吞咽功能障碍是脑卒中患者发生急性应激障碍的主要影响因素(P0.05,P0.01)。结论脑卒中患者急性应激障碍发生率较高,内向性格及存在偏瘫和吞咽功能障碍的患者更容易发生急性应激障碍。医护人员应及时为高危患者提供个体化治疗及预见性护理,防止脑卒中患者发生急性应激障碍。 相似文献
23.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献24.
25.
26.
27.
《Biomaterials》2015
A combination of various therapeutic approaches has emerged as a promising strategy for cancer treatment. A safe and competent nano-delivery system is thus in urgent demand to facilitate the simultaneous transport of various therapeutic agents to cancer cells and a tumor region to achieve synergistic effect. Gold nanoparticles (GNPs) and mesoporous silica nanoparticle (MSNs) were fabricated herein as potential candidates for drug delivery. Serving as gatekeepers, GNPs (5 nm in diameter) were attached onto the amino-functionalized MSNs (denoted as NMSNs) via a relatively weak gold–nitrogen bonding. The resulting nanohybrids (denoted as GCMSNs) were uptaken by cells, and the detachment of GNPs and subsequent intracellular drug release from NMSNs were achieved by competitive binding of intracellular glutathione to GNPs. In addition to the function of gatekeeping, GNPs also play another role as the oxidative stress elicitor. Our in vitro studies revealed that GCMSNs induced higher oxidative stress in lung cancer cells (A549) than in normal cells (3T3-L1). This growth inhibitory effect found in the cancer cells was likely induced by mitochondria dysfunction originated from the GCMSN-induced, oxidative stress-triggered mitochondria-mediated autophagy. The redox-responsive nanohybrids were further loaded with camptothecin and the intensified synergistic therapeutic effects were observed associated with combined chemotherapy and oxidative stress strategy. The results clearly demonstrate that such unique nanohybrids hold great promise for selective and effective cancer treatments. 相似文献
28.
29.
《Journal of vascular and interventional radiology : JVIR》2020,31(6):869-875
This paper describes country-wide special measures undertaken for interventional radiology staff during the current coronavirus disease 2019 (COVID-19) pandemic. Although each interventional radiology service around the world faces unique challenges, the principles outlined in this article will be useful when designing or strengthening individual practices and integrating them within wider hospital and national measures. Moving beyond the current outbreak, these measures will be useful for any future infectious diseases which are likely to arise. 相似文献
30.
《Journal of hand therapy》2020,33(1):60-66
Study DesignClinical commentary.Introduction/PurposePain and movement are universally relevant phenomena that influence human experiences in readily observable ways. Improved understanding of pain-movement relationships can guide medical and rehabilitative approaches to recovery and decrease risk of dysfunctional long-term consequences of otherwise normal neuromuscular responses. Therefore, the overall intent of this article is to elucidate the relationships between pain and movement as they relate to clinical decision making.ConclusionsMotor output is highly adaptable, can be influenced by multiple mechanisms at various levels along the nervous system, and may vary between individuals despite similar diagnoses. Therefore, interventions need to be individualized and consider both the types of motor response observed (ie, whether the response is protective or maladaptive), and the patient's acute physical activity tolerance when prescribing exercise/movement. 相似文献